Novo Nordisk
NVO
#78
Rank
NZ$371.11 B
Marketcap
NZ$83.52
Share price
1.01%
Change (1 day)
-53.83%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): NZ$35.91 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are NZ$47.21 Billion. In 2024 the company made an earning of NZ$32.86 Billion, an increase over its 2023 earnings that were of NZ$26.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$35.91 B9.28%
2024 NZ$32.86 B22.84%
2023 NZ$26.75 B57.81%
2022 NZ$16.95 B5.24%
2021 NZ$16.11 B12.38%
2020 NZ$14.33 B13.11%
2019 NZ$12.67 B-3.45%
2018 NZ$13.12 B1.88%
2017 NZ$12.88 B4.3%
2016 NZ$12.35 B10.32%
2015 NZ$11.19 B7.47%
2014 NZ$10.41 B3.4%
2013 NZ$10.07 B19.09%
2012 NZ$8.46 B15.58%
2011 NZ$7.32 B16.58%
2010 NZ$6.28 B25.66%
2009 NZ$4.99 B10.68%
2008 NZ$4.51 B55.82%
2007 NZ$2.89 B7.02%
2006 NZ$2.70 B19.05%
2005 NZ$2.27 B10.55%
2004 NZ$2.05 B
2002 NZ$1.43 B-14.39%
2001 NZ$1.67 B-52.82%
2000 NZ$3.55 B250%
1999 NZ$1.01 B31.21%
1998 NZ$0.77 B34.31%
1997 NZ$0.57 B11.46%
1996 NZ$0.51 B9.03%
1995 NZ$0.47 B-3.15%
1994 NZ$0.48 B-0.67%
1993 NZ$0.49 B45.38%
1992 NZ$0.33 B-13.81%
1991 NZ$0.39 B37.12%
1990 NZ$0.28 B-0.79%
1989 NZ$0.28 B26.2%
1988 NZ$0.22 B24.97%
1987 NZ$0.18 B-0.9%
1986 NZ$0.18 B-7.78%
1985 NZ$0.20 B24.87%
1984 NZ$0.16 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$20.58 B-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.08 B 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.95 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.80 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France